bears123
Mitglied
Angemeldet: 23.05.2018
Beiträge: 778
|
 Verfasst am: 15.12.2018, 04:24 Titel:
|
 |
|
|
|
Transparency Market Research (TMR) has published a new report titled 鈥?em>Gene Delivery System Market 鈥?Global Industry Analysis, Size, Share, Growth, Trends adidas superstar supercolor españa , and Forecast, 2017鈥?025鈥?em>. According to the report, the global gene delivery system market was valued at approximately US$ 2,227.8 Mn in 2016 is projected to expand at a CAGR of over 7.8% from 2017 to 2025, The report suggests that increasing in incidence of chronic diseases adidas superstar slip on españa , rise in technological advancement in administration of drug delivery are projected to boost the market from 2017 to 2025. Key players introduce advanced technologies for drug delivery systems in North America and Europe; therefore, these regions are likely to account for a dominant share of the global gene delivery system market. Changing lifestyle and increase in incidence of chronic diseases in emerging markets such as China and India are likely to boost the market in Asia Pacific. The market in the region is expected to expand at a CAGR of around 8.6% from 2017 to 2025.
High Cost of Gene Delivery Systems is a Key Inhibitor for the Global Gene Delivery System Market
The cost of gene delivery system is significantly high, hence it is not affordable to all income groups. Additionally, lack of reimbursement in developing and under developed countries is likely to restrain the market. For instance, the cost of Spinraza adidas superstar negras españa , marketed by Biogen and used for the treatment of spinal muscular atrophy, is around US$ 750,000 per patient in the first year and US$ 375,000 annually thereafter. The cost of Cinryze, marketed by Viropharma used for the treatment of hereditary angioedema adidas superstar foundation españa , is more than US$ 417,000 per patient per year. Moreover, rise in incidence of rare diseases increases the demand for treatment options. This, in turn, increases the cost of treatment due to less availability. Gene delivery targets only the affected region. Hence adidas superstar flores españa , stringent regulations lead to drug recalls. Therefore, gene delivery drugs are not sold over-the-counter.
Request for Sample Copy of Report @ ;rep_id=41636
Combined Hybrid Delivery System Segment to Lose Market Share
The report offers detailed segmentation of the global gene delivery system market based on delivery system, application, and route of administration. The delivery system is segmented into viral gene delivery system, non-viral gene delivery system adidas superstar blancas españa , and combined hybrid delivery system. The combined hybrid delivery system segment is expected to lose market share during the forecast period primarily due to increase in demand for viral gene delivery system. Rise in incidence of genetic disorders with a different pattern of inheritance increases demand for gene delivery systems worldwide. Increase in application of viral gene delivery for the treatment of several chronic diseases such as cancer fuels the segment. The non-viral gene delivery system segment is likely to maintain market share during the forecast period. Several advantages of non-viral vectors over viral vectors such as lack of immunogenicity, low toxicity, and potential for tissue specificity drive the segment.
Urology Segment to Expand at Considerable Pace during the Forecast Period
Based on application, the oncology segment dominates the global gene delivery system. Increase in incidence of cancer worldwide, drives the segment. According to WHO report (2017) adidas superstar azules españa , around 1 in 6 deaths occurs due to cancer globally. The urology segment accounted for market share of 7.0% in 2016. The segment is a projected to expand at a considerable pace due to increase in number of chronic kidney diseases and rise in incidences of kidney and liver cancer. According to World Kidney Day a global awareness campaign, 8% to 10% of adults have some form of kidney disorder globally.
Inhalation Segment to Lose the Market Share
In terms of route of administration, the injectable segment dominated the market with share of 43.8%. The injectable route of administration is used for rapid drug absorption. Drugs with low oral bioavailability are administered through intramuscular or subcutaneous route. The inhalation accounted for a small share of the market in 2016; however, is expected to lose market share during the forecast period. Drugs used for the treatment of lung diseases such as bronchodilators and steroids are administered through inhalation to achieve rapid action.
Request Report Brochure @ ;rep_id=41636
Asia Pacific to Register Exponential Growth due to Increase in Incidence of Diseases
The market i. Wholesale Jerseys Wholesale Jerseys Online Cheap NBA Jerseys Online Cheap College Jerseys China Nike NBA Jerseys Cheap Authentic Soccer Jerseys Wholesale Authentic MLB Jerseys From China Retro Soccer Jerseys Wholesale Nike NFL Jerseys From China Adidas NHL Jerseys Free Shipping |
|
FAQ
Suchen
Mitgliederliste
Benutzergruppen
Registrieren
Profil
Einloggen, um private Nachrichten zu lesen
Login
